← Leaderboards
Jongyoon Han
Massachusetts Institute Of Technology
$5,739,926
Attributed
$9,837,089
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
FDA$7,795,745 · 3
NIH$2,041,344 · 3
By mechanism
U01$4,795,745 · 1
R01$4,192,070 · 3
P50$433,592 · 1
R21$415,682 · 1
Top collaborators
- Rajeev Ram6 shared
- Anthony J Sinskey6 shared
- Stacy Springs3 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Peter C Dedon$29,387,499
- John S. Wishnok$7,632,021
- Forest M White$24,390,292
- Michael J Cima$7,757,125
- Robert S Langer$47,407,448
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseComplexDevicesCellsProteinsPeptidesSystems BiologySignal TransductionTechnologyMolecularResearch PersonnelMicrosystemsProgramsCell TypeInterestLifeCytokineBiologyCollaborationsMicrofluidic MicrochipsHuman DiseaseMonitorTissuesMass Spectrum Analysis
Grant awards (20)
Continuous Production of Viral Vectors using membraneless Perfusion Culture of Host Cells$600,000
R01 · FY2023 · FD · contact PI
Continuous Production of Viral Vectors using membraneless Perfusion Culture of Host Cells$600,000
R01 · FY2022 · FD · contact PI
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases$400,000
R01 · FY2022 · FD · contact PI
Novel Process Analytic Technology for Continuous Bioprocessses$1,000,000
U01 · FY2021 · FD
Continuous Production of Viral Vectors using membraneless Perfusion Culture of Host Cells$600,000
R01 · FY2021 · FD · contact PI
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases$400,000
R01 · FY2021 · FD · contact PI
Novel Process Analytic Technology for Continuous Bioprocessses$1,000,000
U01 · FY2020 · FD
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases$400,000
R01 · FY2020 · FD · contact PI
Novel Process Analytic Technology for Continuous Bioprocessses$2,795,745
U01 · FY2019 · FD
PROJECT 10$81,624
P50 · FY2012 · GM · contact PI
Continuous-flow, Ampholyte-free pI-based Sorting Peptides/proteins at Extreme pH$185,352
R21 · FY2011 · EB · contact PI
PROJECT 10$82,424
P50 · FY2011 · GM · contact PI
Continuous-flow, Ampholyte-free pI-based Sorting Peptides/proteins at Extreme pH$230,330
R21 · FY2010 · EB · contact PI
PROJECT 10$85,756
P50 · FY2010 · GM · contact PI
PROJECT 10$86,620
P50 · FY2009 · GM · contact PI
Nanofluidic Tools for Proteomic Sample Preparation$292,933
R01 · FY2008 · EB · contact PI
PROJECT 10$97,168
P50 · FY2008 · GM · contact PI
Nanofluidic Tools for Proteomic Sample Preparation$290,299
R01 · FY2007 · EB · contact PI
Nanofluidic Tools for Proteomic Sample Preparation$301,278
R01 · FY2006 · EB · contact PI
Nanofluidic Tools for Proteomic Sample Preparation$307,560
R01 · FY2005 · EB